John Bell

John Bell is a Senior Scientist at the Ottawa Hospital Research Institute. For more than twenty years, he and his team have been developing cancer-fighting (oncolytic) viruses. John is a Co-founder of Turnstone Biologics a San Diego company developing novel biotherapeutics to treat and cure patients with solid tumors. He is the Scientific Director of BioCanRx, a not-for-profit organization working to accelerate the development of innovative immunotherapeutics, designed to save lives and enable a better quality of life for Canadian cancer patients.

John was elected as a fellow of the Royal Society of Canada in 2013 and the Canadian Academy of Health Sciences in 2022. He holds Bachelor’s and Ph.D. degrees from McMaster University.

John serves on the Board of the Terry Fox Research Institute and was elected to the Biologics Manufacturing Centre Board of Directors in December 2023.